2.2.0.25truefalse40502 - Disclosure - ACQUISITIONS (Purchase Price Allocation) (Details)truefalseIn Millions, unless otherwise specifiedfalse1falsefalseUSDtruefalse{us-gaap_SubsequentEventTypeAxis} : Pegylated-Interferon Lambda [Member]
{dei_LegalEntityAxis} : ZymoGenetics Acquisition [Member]
{us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis} : In-Process Research and Development [Member]
12/31/2010
USD ($)
$As_Of_12_31_2010358http://www.sec.gov/CIK0000014272instant2010-12-31T00:00:000001-01-01T00:00:00falsefalsePegylated-Interferon Lambda [Member]us-gaap_SubsequentEventTypeAxisxbrldihttp://xbrl.org/2006/xbrldibmy_PegylatedInterferonLambdaMemberus-gaap_SubsequentEventTypeAxisexplicitMemberfalsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberfalsefalseIn-Process Research and Development [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldibmy_InProcessResearchAndDevelopmentMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2falsefalsetruefalse{us-gaap_SubsequentEventTypeAxis} : Recothrom [Member]
{dei_LegalEntityAxis} : ZymoGenetics Acquisition [Member]
10/1/2009 - 12/31/2009
Duration_10_1_2009_To_12_31_2009224http://www.sec.gov/CIK0000014272duration2009-10-01T00:00:002009-12-31T00:00:00falsefalseRecothrom [Member]us-gaap_SubsequentEventTypeAxisxbrldihttp://xbrl.org/2006/xbrldibmy_RecothromMemberus-gaap_SubsequentEventTypeAxisexplicitMemberfalsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit13Standardhttp://www.xbrl.org/2003/instancepurexbrli03falsefalseUSDtruefalse{dei_LegalEntityAxis} : ZymoGene
tics Acquisition [Member]
12/31/2010
USD ($)
$As_Of_12_31_20104http://www.sec.gov/CIK0000014272instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4falsefalseUSDtruefalse{dei_LegalEntityAxis} : ZymoGenetics Acquisition [Member]
10/31/2010
USD ($)
$As_Of_10_31_2010http://www.sec.gov/CIK0000014272instant2010-10-31T00:00:000001-01-01T00:00:00falsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USD<
MeasureNamespace>iso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2false0us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaidus-gaaptruedebitinstantNo definition available.falsefalsefalse
falsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse<
NumericAmount>00falsefalsefalsetruefalse3truefalsefalse885000000885falsetruefalsetruefalse4truefalsefalse<
NumericAmount>885000000885falsetruefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of cash paid to acquire the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph f(1)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph d
falsefalse3false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalentsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3t
ruefalsefalse5600000056falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of cash and cash equivalents acquired in a business combination.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
falsefalse4false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsMarketableSecuritiesus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse9100000091falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to marketable securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 37
-Subparagraph a
falsefalse5false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventoryus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse9800000098[1]falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to inventory, including finished goods, work-in-process, and raw materials.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 37
-Subparagraph c
falsefalse6false0bmy_BusinessAcquisitionPurchasePriceAllocationOtherCurrentAndNonCurrentAssetsbmyfalsedebitinstantThe amount of acquisition cost of a business combination allocated to other current and other noncurrent assets.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel<
/PreferredLabelRole>1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse2900000029falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to other current and other noncurrent assets.No authoritative reference available.falsefalse7false0us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizableus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse310000000310falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse448000000448[2]falsefalsefalsetruefalse4falsefalsefal
se00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will not be amortized. Does not include goodwill.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-Subparagraph b
falsefalse8false0us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse230000000230[3]falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will be amortized.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
falsefalse9false0us-gaap_BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1
falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse90000009falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of deferred tax assets or liabilities for the differences between the values assigned and the tax bases of assets and liabilities in a business combination, net of any valuation allowance for deferred tax assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 38
falsefalse10false0bmy_BusinessAcquisitionPurchasePriceAllocationOtherCurrentAndNoncurrentLiabilitiesbmyfalsecreditinstantThe amount of acquisition cost of a business combination allocated to other current and noncurrent liabilities of the...falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse-91000000-91falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to other current and noncurrent liabilities of the acquired entity.No authoritative reference available.falsefalse11false0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse870000000870falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe net amount recognized as of the acquisition date for the aggregate identifiable assets acquired in excess of or less than the aggregate liabilities assumed.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph i
falsefalse12false0us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmountus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1fals
efalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse1500000015falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of goodwill arising from a business combination, which is the excess of the cost of the acquired entity over the amounts assigned to assets acquired and liabilities assumed.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-Subparagraph c
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 53
-Subparagraph d
falsefalse13false0us-gaap_OtherInventoryNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsetruefalse2falsefalsefalse00falsefalsefalsetruefalse3truefalsefalse6300000063falsetruefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryI
temTypemonetaryCarrying amount as of the balance sheet date of inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle (such as inventory related to long-term contracts or program rights).Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 3
-Section A
-Paragraph 4, 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 6
-Subparagraph d
-Article 5
falsefalse14false0us-gaap_FiniteLivedIntangibleAssetsUsefulLifeus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsetruefalse2truefalsefalse1010falsefalsefalsetruefalse3falsefalsefalse00falsefalsefalsetruefalse4falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:integerItemTypeintegerThe useful life of all finite-lived intangible assets. This may be stated as a fixed number (for example, 10 years) if all assets have the same useful life, or it can be stated in a range (for example, six to eight years) if there is a range of useful lives in the asset group.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 12, 13, 14
falsefalse1Includes $63 million recorded in other long term assets as inventory that is expected to be utilized in excess of one year. 2Includes $310 million related to pegylated-interferon lambda. 3Attributed to RECOTHROM which is amortized over 10 years. 413ACQUISITIONS (Purchase Price Allocation) (Details) (ZymoGenetics Acquisition [Member], USD $)MillionsUnKnownUnKnownUnKnowntruetrue
